Cipla, a leading Indian drugs company, has made a renewed bid to buy one of its customers, South Africa’s Cipla Medpro, in a deal worth R4.5 billion ($512 million). Medpro’s board of directors intends to recommend Cipra’s offer, which will be through a scheme of arrangement rather than a tender.
¬ Haymarket Media Limited. All rights reserved.
